Vertex Pharmaceuticals Incorporated ( VRTX) Citi Annual Global Healthcare Conference 2025 December 3, 2025 9:00 AM EST ...
Zacks Investment Research on MSN
Why Is Vertex (VRTX) Up 2.7% Since Last Earnings Report?
It has been about a month since the last earnings report for Vertex Pharmaceuticals (VRTX). Shares have added about 2.7% in that time frame, outperforming the S&P 500. But investors have to be ...
Zacks Investment Research on MSN
Vertex Up 9.2% in 3 Months: Should You Buy, Sell or Hold the Stock?
Vertex Pharmaceuticals Incorporated VRTX stock has risen 9.2% in the past three months. However, the stock has significantly ...
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) caught the attention of investors this week as Morgan Stanley analyst Terence Flynn upgraded the stock to an “Overweight” rating o. Coupled with an ...
The Dow boasts a triple-digit gain midday, but the S&P 500 and Nasdaq are inching higher amid jobs data and Bitcoin volatility ...
Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...
Vertex Pharmaceuticals Up Over 5%, on Pace for Largest Percent Increase Since November 2024 — Data Talk Vertex Pharmaceuticals Incorporated (VRTX) is currently at $457.50, up $24.36 or 5.62% ...
Wall Street trading got off to a mixed start on Wednesday, as investors weighed the prospect of a year‑end rally and digested ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback